Valopicitabine (NM283) Combined with Pegylated Interferon Demonstrated Significantly Greater Suppression of He (Hep C)
Valopicitabine (NM283) Combined with Pegylated Interferon Demonstrated Significantly Greater Suppression of He
PR Newswire - SAN FRANCISCO, Nov. to retreatment with ribavirin pluspegylated interferon in chronic hepatitis C, genotype 1 patients who were non
Chronic Hepatitis C in the Elderly: Many Patients, Few Data
HIV and Hepatitis.com - Chronic infection is prevalent in elderly patients and may be more severe than in younger adults. As middle aged patients with HIV infection become elderly, the number of individuals with liver disease related to chronic hepatitis C will grow. in the . The burden of chronic hepatitis C virus infection in elderly
MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio
BioSpace - 1 inhibitor, in development for the treatment of chronic hepatitis C virus (HCV) infections the success of treatment for patients suffering from chronic hepatitis C infections
Actilon(TM), Coley Pharmaceutical Group's Drug Candidate For Hepatitis C, Demonstrates Anti-Viral Activity In
BioSpace - as well as long-term control of chronic Hepatitis C. Clinical results to date justify longer-term Phase Ib randomized clinical trial of Actilon in chronic Hepatitis C patients
